BEGIN:VCALENDAR
PRODID:-//eluceo/ical//2.0/EN
VERSION:2.0
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:f7952be8f81eb519d1e7c39d5b2e2282
DTSTAMP:20260719T131225Z
SUMMARY:Converging on Cancer: International Seminar Series – Dr Lisa Adam
 s (TUM) and Prof Eric Aboagye (Imperial)
DESCRIPTION:The CRUK Convergence Science Centre is a partnership between Im
 perial College London and The Institute of Cancer Research. In collaborati
 on with our international partners we arrange a regular international semi
 nar ‘Converging on Cancer’ on the topic of interdisciplinary cancer re
 search. Our partners are:\n\nTechnical University of Munich (TUM)\nNanyang
  Technological University (NTU)\nBiotech Research and Innovation Centre (B
 RIC – University of Copenhagen)\nÉcole Polytechnique Fédérale de Laus
 anne (EPFL).\n\n\nIn this series\, we bring together speakers from across 
 these institutions to present their research and how they use convergence 
 science to answer cancer-related questions. This seminar will focus on Com
 putation and AI in medical decisions.\nThis session will be chaired by Cl
 aus Storgaard Sørensen (BRIC\, Copenhagen).\nThursday 7th May\, 10-11am 
 BST\, 11-12pm CEST\, 5-6pm SGT\n\nSpeakers\nDr Lisa Adams (TUM)\nCan AI t
 hink like an oncologist? \nLessons from agentic reasoning\, body composit
 ion analysis\, and predictive laboratory modelling in cancer. Recent advan
 ces in AI are moving beyond pattern recognition toward systems that can re
 ason\, plan\, and act\, capabilities increasingly relevant to oncology. Th
 is talk explores three converging lines of work: agentic AI systems that e
 mulate clinical reasoning workflows\, automated body composition analysis 
 from routine imaging as a prognostic biomarker in cancer\, and predictive 
 modelling of laboratory trajectories to anticipate clinical deterioration.
  Together\, these approaches illustrate how AI might begin to approximate 
 – and augment – the integrative thinking of an oncologist\, while high
 lighting the challenges and limitations that remain on the path from proof
 -of-concept to clinical impact.\n \nProf Eric Aboagye (Imperial)\nProgno
 stic insights from analysing the mesoscopic architecture of human tumours\
 nRoutinely acquired human images including ultrasound\, CT\, MRI and PET\,
  contain more information that we can appreciate with the naked eye. Bridg
 ing between macroscopic phenomena and mesoscopic scale\, aims to provide u
 niversal patterns and new phenotypes of the entire tumour lesion(s). The t
 alk focuses on development and application of radiomic models to understan
 d mesoscopic tumour architecture\, and  consequently vectors or phenotype
 s of prognostic relevance.\n\n \n\nWho can attend?\nResearchers\, student
 s and anyone with an interest in convergence science relating to cancer re
 search across our partnered institutions are welcome to register:\n\nCRU
 K Convergence Science Centre\nImperial College London\nThe Institute of Ca
 ncer Research (ICR)\nTechnical University of Munich (TUM)\nNanyang Technol
 ogical University (NTU)\nBiotech Research and Innovation Centre (BRIC – 
 University of Copenhagen)\nÉcole Polytechnique Fédérale de Lausanne (EP
 FL)\nCRUK Cambridge Centre\nCRUK City of London Centre (Kings college\, UC
 L\, Barts Cancer Institute/Queen Mary University\, Francis Crick)\nCRUK Ma
 nchester Centre\nCRUK Newcastle Centre\nCRUK Oxford Centre\nCRUK Scotland 
 Centre (University of Edinburgh and University of Glasgow)\n\n \nEmail ic
 r-imperial-convergence.centre@imperial.ac.uk to receive the registration l
 ink and joining details.\n 
URL:https://www.imperial.ac.uk/events/208223/converging-on-cancer-internati
 onal-seminar-series-dr-lisa-adams-tum-and-prof-eric-aboagye-imperial/
DTSTART;TZID=Europe/London:20260507T100000
DTEND;TZID=Europe/London:20260507T110000
LOCATION:United Kingdom
END:VEVENT
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
DTSTART:20260507T100000
TZNAME:BST
TZOFFSETTO:+0100
TZOFFSETFROM:+0100
END:DAYLIGHT
END:VTIMEZONE
END:VCALENDAR